Hambleton Julie - Insider Non-Derivative Transactions at SpringWorks Therapeutics, Inc. (SWTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 3, 2024, Hambleton Julie's relationship to SpringWorks Therapeutics, Inc. (SWTX) is Director, and currently has 5,797 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SWTX insiders.
Data Source: SEC.
Hambleton Julie - Insider Non-Derivative Transactions of SWTX Common Stock
Hambleton Julie - Insider Non-Derivative Transactions at SWTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 4, 2024 | Sell -- (Common Stock) | 20 | 42.09 | 4095 |
| Jun 4, 2024 | Sell -- (Common Stock) | 931 | 41.49 | 4115 |
| Jun 4, 2024 | Sell -- (Common Stock) | 751 | 40.57 | 5046 |
| Jun 4, 2024 | Sell -- (Common Stock) | 2946 | 39.41 | 5797 |
| May 17, 2024 | Acquisition -- (Common Stock) | 4095 | 0 | 8743 |
| Jul 20, 2023 | Sell -- (Common Stock) | 2418 | 29.31 | 4648 |
| Jun 21, 2023 | Sell -- (Common Stock) | 2400 | 26.92 | 7066 |
| May 25, 2023 | Acquisition -- (Common Stock) | 4648 | 0 | 9466 |
| Mar 16, 2023 | Sell -- (Common Stock) | 1106 | 31.5 | 4818 |